Literature DB >> 23831572

Ras signaling is essential for skin development.

M Drosten1, C G Lechuga1, M Barbacid1.   

Abstract

Proliferation in the epidermis is a tightly controlled process. During skin development, epidermis formation and hair follicle morphogenesis crucially depend on the regulated balance between proliferation and differentiation. Here we deleted all three Ras loci (H-Ras, N-Ras and K-Ras) from keratinocytes in vitro as well as specifically from the epidermis in mice using a K5Cre strain. Upon Ras elimination, keratinocytes ceased proliferation and entered into senescence without any signs of apoptosis induction. Constitutive activation of the mitogen-activated protein kinase pathway was able to partially rescue the proliferative defects. In mice, Ras signaling was essential for proper development of the epidermis and hair follicles. Deletion of the three Ras loci during epidermis formation in mouse embryos caused a dramatic decrease in proliferation, resulting in a substantially thinner epidermis and delayed appearance of differentiation markers. We could not detect apoptotic or senescent cells in these embryos suggesting that loss of Ras protein expression only leads to severe hypoproliferation. These observations provide genetic evidence for an essential role of Ras proteins in the control of keratinocyte and epidermal proliferation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23831572     DOI: 10.1038/onc.2013.254

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  19 in total

Review 1.  RAS-targeted therapies: is the undruggable drugged?

Authors:  Amanda R Moore; Scott C Rosenberg; Frank McCormick; Shiva Malek
Journal:  Nat Rev Drug Discov       Date:  2020-06-11       Impact factor: 84.694

2.  Differential Role of the RasGEFs Sos1 and Sos2 in Mouse Skin Homeostasis and Carcinogenesis.

Authors:  Pilar Liceras-Boillos; David Jimeno; Rósula García-Navas; L Francisco Lorenzo-Martín; Mauricio Menacho-Marquez; Carmen Segrelles; Carmela Gómez; Nuria Calzada; Rocío Fuentes-Mateos; Jesús M Paramio; Xosé R Bustelo; Fernando C Baltanás; Eugenio Santos
Journal:  Mol Cell Biol       Date:  2018-07-30       Impact factor: 4.272

3.  Ras and p53: An unsuspected liaison.

Authors:  Matthias Drosten; Mariano Barbacid
Journal:  Mol Cell Oncol       Date:  2015-01-23

4.  Comparison of hair manifestations in cardio-facio-cutaneous and Costello syndromes highlights the influence of the RAS pathway on hair growth.

Authors:  J Urban; L Qi; H Zhao; I Rybak; K A Rauen; M Kiuru
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-01-02       Impact factor: 6.166

5.  Targeting Cellular Senescence with Senotherapeutics: Development of New Approaches for Skin Care.

Authors:  Elizabeth L Thompson; Louise E Pitcher; Laura J Niedernhofer; Paul D Robbins
Journal:  Plast Reconstr Surg       Date:  2021-09-28       Impact factor: 5.169

Review 6.  Expanding the Reach of Precision Oncology by Drugging All KRAS Mutants.

Authors:  Marco H Hofmann; Daniel Gerlach; Sandra Misale; Mark Petronczki; Norbert Kraut
Journal:  Cancer Discov       Date:  2022-04-01       Impact factor: 38.272

7.  Ras in epidermal proliferation.

Authors:  Matthias Drosten; Carmen G Lechuga; Mariano Barbacid
Journal:  Oncotarget       Date:  2014-07-30

8.  Loss of p53 induces cell proliferation via Ras-independent activation of the Raf/Mek/Erk signaling pathway.

Authors:  Matthias Drosten; Eleanor Y M Sum; Carmen G Lechuga; Lucía Simón-Carrasco; Harrys K C Jacob; Raquel García-Medina; Sidong Huang; Roderick L Beijersbergen; Rene Bernards; Mariano Barbacid
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-06       Impact factor: 11.205

Review 9.  Genetic analysis of Ras genes in epidermal development and tumorigenesis.

Authors:  Matthias Drosten; Carmen G Lechuga; Mariano Barbacid
Journal:  Small GTPases       Date:  2013-10-22

10.  Investigation of Candidate Genes and Pathways in Basal/TNBC Patients by Integrated Analysis.

Authors:  Qi Liu; Xiang Song; Zhaoyun Liu; Zhiyong Yu
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.